Search results for "Poly(ethylene glycol)"

showing 10 items of 337 documents

Aggregation behavior of cationic nanohydrogel particles in human blood serum.

2014

For systemic siRNA delivery applications, well-defined drug carriers are required that guarantee stability for both carrier and cargo. Among various concepts progressing in market or final development, cationic nanohydrogel particles may serve as novel transport media especially designed for siRNA-in vivo experiments. In this work, the interaction of nanohydrogel particles with proteins and serum components was studied via dynamic light scattering in human blood serum as novel screening method prior to applications in vivo. The formation of larger aggregates mostly caused by charge interaction with albumin could be suppressed by nanogel loading with siRNA affording a neutral zeta potential …

SerumPolymers and PlasticsLightNanogelsBioengineeringNanotechnologyPolyethylene GlycolsBiomaterialsDynamic light scatteringIn vivoCationsMaterials ChemistryZeta potentialHumansPolyethyleneimineScattering RadiationRNA Small InterferingDrug CarriersHuman bloodChemistryAlbuminCationic polymerizationHydrogelsBiophysicsDrug carrierNanogelBiomacromolecules
researchProduct

POLYMERIC MICELLES BASED ON A PHOSPHOLIPID/ POLYASPARTAMIDIC COPOLYMER FOR BECLOMETHASONE DIPROPIONATE DELIVERY TO THE LUNGS

2010

Settore CHIM/09 - Farmaceutico Tecnologico Applicativoalphabeta-poly(N-2-hydroxyethyl)-DL-aspartamide (PHEA) 12-Distearoyl-sn-glycero-3-Phosphoethanolamine-N-[Amino(Polyethylene glycol)2000] (DSPE-PEG2000-NH2) polymeric micelles drug delivery beclomethasone dipropionate (BDP) pulmonary diseases.
researchProduct

Surface AFM microscopy of unworn and worn samples of silicone hydrogel contact lenses

2008

Abstract: Purpose. To evaluate the qualitative and quantitative topographic changes in the surface of worn contact lenses (CLs) of different materials using atomic force microscopy (AFM). Methods. The topography of five different CL materials was evaluated withAFM over a surface of 25 lm2 according to previously published experimental setup. Average roughness (Ra) and root mean square (Rms) values were obtained for unworn and worn samples. Results. The Ra value increased for balafilcon A (11.62–13.68 nm for unworn and worn samples, respectively), lotrafilcon A (3.67–15.01 nm for unworn and worn samples, respectively), lotrafilcon B (4.08–8.42 nm for unworn and worn samples, respectively), g…

SiliconSurface characterizationwearMaterials scienceContact LensesSurface PropertiesSiliconesBiomedical Engineering02 engineering and technologySurface finishMicroscopy Atomic ForceHydrogel Polyethylene Glycol DimethacrylateBiomaterialsAtomic force microscopyPolymer deterioration03 medical and health sciences0302 clinical medicineOpticsMaterials TestingMicroscopySurface roughnessComposite materialdegradationScience & TechnologyAtomic force microscopybusiness.industryHydrogelsLotrafilcon BContact lensSilicone hydrogelContact Lenses Hydrophilic021001 nanoscience & nanotechnologyContact lensPseudomonas aeruginosaWettability030221 ophthalmology & optometryWetting0210 nano-technologybusinessJournal of Biomedical Materials Research Part B: Applied Biomaterials
researchProduct

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1)…

2014

Although the addition of the HCV NS3/4A protease inhibitors boceprevir and telaprevir to pegylated interferon (peginterferon) alfa plus ribavirin has improved sustained virological response (SVR) in treatment-naive and treatment-experienced patients infected with hepatitis C virus (HCV) genotype 1, the regimens have a high pill burden and are associated with increased rates and severity of adverse events, such as anaemia and rash. The efficacy and safety of the combination of simeprevir, a one pill, once-daily, oral HCV NS3/4A protease inhibitor, plus peginterferon alfa 2a plus ribavirin were assessed in treatment-naive patients with HCV genotype 1 infection.In QUEST-1, a phase 3, randomise…

SimeprevirAdultMalemedicine.medical_specialtyGenotypeHepatitis C virusHepacivirusmedicine.disease_causeGastroenterologyAntiviral AgentsDrug Administration ScheduleTelaprevirPolyethylene Glycolschemistry.chemical_compoundDouble-Blind MethodPegylated interferonSimeprevirBoceprevirInternal medicineRibavirinmedicineHumanschronic hepatitis CSulfonamidesbusiness.industryRibavirinvirus diseasesInterferon-alphaGeneral MedicineHepatitis CHepatitis C ChronicMiddle Agedmedicine.diseaseVirologydigestive system diseasesRecombinant ProteinsTreatment OutcomechemistryDrug Therapy CombinationFemalebusinessHeterocyclic Compounds 3-Ringmedicine.drugPeginterferon alfa-2a
researchProduct

Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) …

2017

Background HCV GT4 accounts for up to 20% of HCV infections worldwide. Simeprevir, given for 12 weeks as part of a 24- or 48-week combination regimen with PR is approved for the treatment of chronic HCV GT4 infection. Primary study objectives were assessment of efficacy and safety of simeprevir plus PR in treatment-naïve patients with HCV GT4 treated for 12 weeks. Primary efficacy outcome was sustained virologic response 12 weeks post-treatment (SVR12). Additional objectives included investigation of potential associations of rapid virologic response and baseline factors with SVR12. Methods This multicentre, open-label, single-arm study (NCT01846832) evaluated efficacy and safety of simepre…

SimeprevirMalePsychologie appliquéeFetge - MalaltiesHepacivirusGastroenterologyPolyethylene GlycolPolyethylene Glycols0302 clinical medicinelcsh:Science61 - MedicinaLiver DiseasesSciences bio-médicales et agricolesCirrhosisInterferonLiver Fibrosis030211 gastroenterology & hepatologyDrug Therapy CombinationViral loadBiologieHumanmedicine.medical_specialtyCiències multidisciplinàriesGenotypeSaudi ArabiaAlpha interferon:Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores]Gastroenterology and HepatologyMicrobiologyAntiviral Agents03 medical and health sciencesHumansAgedMedicine and health sciencesHepaciviruFlavivirusesInterleukinslcsh:ROrganismsInterleukinmedicine.diseaseRegimen:Digestive System Diseases::Liver Diseases [DISEASES]chemistryImmunologylcsh:QMedicaments - AdministracióDevelopmental BiologyRNA viruseslcsh:Medicinemedicine.disease_cause:Other subheadings::Other subheadings::/drug therapy [Other subheadings]Geographical Locationschemistry.chemical_compoundSimeprevirHospital Universitari Vall d’Hebron030212 general & internal medicinePathology and laboratory medicineMultidisciplinaryHepatitis C virusHepatitis CRecombinant ProteinMedical microbiologyMiddle AgedViral LoadHepatitis CRecombinant Proteins:enfermedades del sistema digestivo::enfermedades hepáticas [ENFERMEDADES]EuropeResearch DesignVirusesFemalePathogensResearch ArticleAdultAsiaAdolescentClinical Research DesignHepatitis C virusResearch and Analysis MethodsYoung AdultInternal medicineRibavirinmedicineddc:610Rapid Virologic ResponseAntiviral AgentBiology and life sciencesbusiness.industryRibavirinViral pathogensInterferon-alphaFibrosisHepatitis virusesMicrobial pathogensPeople and PlacesAdverse EventsInterferonsbusinessPLoS ONE
researchProduct

Development of a novel rapamycin loaded nano- into micro-formulation for treatment of lung inflammation

2022

AbstractIt has recently emerged that drugs such as the mTOR inhibitor rapamycin (Rapa) may play a key role in the treatment of airway inflammation associated with lung diseases, such as chronic obstructive pulmonary disease, asthma, and cystic fibrosis. Nevertheless, Rapa clinical application is still prevented by its unfavorable chemical-physical properties, limited oral bioavailability, and adverse effects related to non-specific biodistribution. In this paper, the design and production of a novel formulation of Rapa based on nano into micro (NiM) particles are detailed. To achieve it, Rapa-loaded nanoparticles were produced by nanoprecipitation of an amphiphilic pegylated poly-ɛ-caprolac…

SirolimusInflammationPharmaceutical SciencePneumoniaMicroparticlesPolyethylene GlycolsNanoparticleMicroparticleSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoHumansNanoparticlesPulmonary administrationTissue DistributionRapamycinParticle SizePowdersLung
researchProduct

Bioadhesive monolayer film for the in vitro transdermal delivery of sumatriptan

2006

The work presented here aims to develop a bioadhesive monolayer film containing sumatriptan as adjuvant for the treatment of headache pain in a severe migraine attack. Permeation experiments were performed from the films prepared and from the respective solution, to evaluate the relevant permeation parameters. The effect of the penetration enhancers Transcutol, 2-pyrrolidone, and polyethylene glycol 600 was evaluated. The results obtained show that Transcutol and 2-pyrrolidone decreased sumatriptan permeation from solution, whereas a modest increase was produced by polyethylene glycol 600. The enhancers produced the same effects when they were included in the film. Compared to solution, the…

Skin AbsorptionBioadhesivePharmaceutical SciencePolyethylene glycolIn Vitro TechniquesPharmacologyAdministration CutaneousPermeabilityDosage formPolyethylene Glycolschemistry.chemical_compoundDrug Delivery SystemsMonolayerAnimalsVasoconstrictor AgentsMedicineSkinTransdermalSumatriptanbusiness.industryPenetration (firestop)PermeationPyrrolidinonesSumatriptanchemistryEthylene GlycolsRabbitsbusinessBiomedical engineeringmedicine.drugJournal of Pharmaceutical Sciences
researchProduct

Combination strategies for enhancing transdermal absorption of sumatriptan through skin

2006

The aim of the present work was to characterize in vitro sumatriptan transdermal absorption through human skin and to investigate the effect of chemical enhancers and iontophoresis applied both individually and in combination. A secondary objective was to compare the results obtained with those in porcine skin under the same conditions, in order to characterize the relationship between the two skin models and validate the porcine model for further research use. Transdermal flux of sumatriptan was determined in different situations: (a) after pre-treatment of human skin with ethanol, Azone (1-dodecyl-azacycloheptan-2-one), polyethylene glycol 600 and R-(+)-limonene, (b) under iontophoresis a…

Skin AbsorptionSus scrofaPharmaceutical ScienceHuman skinPolyethylene glycolAbsorption (skin)In Vitro TechniquesPharmacologyAdministration CutaneousPolyethylene Glycolschemistry.chemical_compoundSumatriptan SuccinateCyclohexenesmedicineAnimalsHumansAdjuvants PharmaceuticSkinTransdermalEthanolintegumentary systemIontophoresisSumatriptanTerpenesAzepinesIontophoresisSerotonin Receptor AgonistsSumatriptanchemistryLimoneneAzoneBiomedical engineeringmedicine.drugInternational Journal of Pharmaceutics
researchProduct

LC of high to moderately polar basic drugs in urine with water and detergent, and direct injection

2016

Background: Micellar LC was first proposed as a ‘green’ mode using mobile phases of water and surfactant. However, in most procedures a small amount of organic solvent is required to decrease the retention to convenient values. Results & methodology: Mixed micellar mobile phases prepared with both cationic (sodium dodecyl sulphate) and nonionic surfactant (Brij-35) modulate the retention of high to moderately polar basic drugs to practical times, eliminating the need of organic solvent. While the mobile phase is continuously recycled through the system, the stationary phase performance is maintained after repetitive injection of the samples. Discussion & conclusion: Through an exte…

SodiumClinical Biochemistrychemistry.chemical_elementUrine010402 general chemistry01 natural sciencesPolyethylene GlycolsAnalytical ChemistrySurface-Active AgentsPulmonary surfactantLimit of DetectionPhase (matter)HumansGeneral Pharmacology Toxicology and PharmaceuticsMicellesChromatographyChemistryOrganic solvent010401 analytical chemistryCationic polymerizationSodium Dodecyl SulfateWaterGeneral Medicine0104 chemical sciencesMedical Laboratory TechnologyPharmaceutical PreparationsStationary phaseFlow Injection AnalysisPolarChromatography LiquidBioanalysis
researchProduct

Potassium Triggers a Reversible Specific Stiffness Transition of Polyethylene Glycol

2017

We use plasmon rulers made from two connected gold nanoparticles to monitor the conformation and stiffness of single PEG molecules and their response to cations. By observing equilibrium fluctuations of the interparticle distance, we obtain the spring constants or stiffness of the connecting single-molecule tether with pico-Newton sensitivity. We observe a transition of the PEG molecules’ extension and stiffness above about 1.2 mM K+ ion concentration which is specific to potassium ions. Molecular dynamics simulations reveal the formation of crown-like structures as the most likely molecular mechanism responsible for this specific effect.

StereochemistryPotassiumchemistry.chemical_elementmacromolecular substances02 engineering and technologyPolyethylene glycol010402 general chemistry01 natural sciencesIonchemistry.chemical_compoundMolecular dynamicsmedicineMoleculePhysical and Theoretical ChemistrySpecific modulustechnology industry and agricultureStiffness021001 nanoscience & nanotechnology0104 chemical sciencesSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsGeneral EnergychemistryColloidal goldChemical physicsmedicine.symptom0210 nano-technologyThe Journal of Physical Chemistry C
researchProduct